Aura Biosciences (AURA) Treasury Shares (2021 - 2026)

Aura Biosciences has reported Treasury Shares for 6 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 19.42% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 19.42% YoY), and the FY2025 full-year result was $2.7 million, up 69.33% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.3 million, up from $2.7 million in the prior quarter.
• The five-year high for Treasury Shares was $3.3 million in Q1 2026, with the low at $153950.0 in Q4 2022.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares tumbled 33.62% — and 2023, when it jumped 610.23%.
• Aura Biosciences' Treasury Shares stood at $153950.0 in 2022, then jumped by 610.23% to $1.1 million in 2023, then surged by 45.33% to $1.6 million in 2024, then soared by 69.33% to $2.7 million in 2025, then gained by 22.13% to $3.3 million in 2026.
• The last three Treasury Shares figures came in at $3.3 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.